The Role of a Clinical Pharmacist in Lifestyle Modification
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Hawler Medical University
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Estimating Summary of diabetes self-care activity (SDSCA)
Study Overview
Brief Summary
The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patients (diabetes type, diabetes duration, HbA1c, body mass index, hypertension, total cholesterol) and the diabetic peripheral neuropathy DPN and the rational poly pharmacy used to control pain.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Double (Care Provider, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Aged 18 years or older.
- •Diagnosed with type 2 diabetes at least one year previously.
- •Took at least one prescribed medication for diabetes.
- •Diagnosed as diabetic peripheral neuropathy based on clinical
Exclusion Criteria
- •History of alcohol consumption.
- •Thyroid gland disorder.
- •Any kidney disorder.
- •Any conditions that could confound assessment of pain due to diabetic peripheral neuropathy.
- •Have foot injury or open sore.
- •Pregnant females or who plan to become pregnant during the study period.
- •Any serious medical condition that might prevent completion or hinder compliance with exercise.
Arms & Interventions
Intervention Group
The intervention group will receive the three months' lifestyle modification program by a clinical pharmacist.
Intervention: Diabetic patients with neuropathy (Other)
Usual care Group
The usual care group will be provided the standard medical services
Outcomes
Primary Outcomes
Estimating Summary of diabetes self-care activity (SDSCA)
Time Frame: Three months
Assessing Lifestyle modification by summary of diabetes self-care activity (SDSCA) at baseline visit and after three months for both Intervention patients and usual care group Increases in the means of the items of the scale as Exercise, Blood sugar testing, Specific diet and Foot care in the intervention group.
Adherence to treatment according to Morisky scale
Time Frame: Three months
Morisky scale is used to assess medication adherence at baseline visit and after three months for both Intervention patients and usual care group. Improving the patient medication adherence behavior in the intervention group patients
Douleur Neuropathique 4 (DN4), Neuropathic Pain Scale (NPS),
Time Frame: Three months
Reduction in the percent of response of patients feeling; electric shock, tingling, and pin needle after the lifestyle modification in the intervention group.
Secondary Outcomes
No secondary outcomes reported
Investigators
Kawa Dizaye
Professor of Pharmacology
Hawler Medical University